Recent Finacing
Recent Raise
Harpoon Therapeutics is a clinical-stage immunotherapy company developing tri-specific T-cell engager TriTAC and ProTriTAC platforms, advancing PSMA-targeting HPN424 in Phase 1 and programs for mesothelin and BCMA.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
